The Week in Review: Oct 19 – Oct 26, 2018

Friday, Oct 26, 2018 News Recap: HepCBC Annual General Meeting INVITATION TO ALL We invite everyone to have a say in the direction of HepCBC, a BC-wide patient advocacy group confronting Viral Hepatitis since 1996, through participation in our upcoming Annual General Meeting (AGM) – either in person or online! 7th Annual Liver Forum 2018 in Vancouver! On October 19th, Volunteers Douglas Laird and Cheryl Reitz of HepCBC attended the exciting 7th ...

Interleukin IL-22, a new target to inhibit the progression of liver disease

Montreal, October 26, 2018 - Naglaa Shoukry, Ph. D., and her team have made a significant breakthrough in their research aiming to limit the progression of liver disease. They have characterized the mechanisms of action of type 3 inflammatory cytokines that are produced by the cells of the immune system, which result in a progression of hepatic scarring known as fibrosis. These research efforts have identified new potential targets to inhibit the progressi